Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2010
06/03/2010US20100137196 Histone deacetylases, and uses related thereto
06/03/2010US20100137195 Production of Recombinant IL-18 Binding Protein
06/03/2010US20100137194 Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism
06/03/2010US20100137193 Chitosan derivatives to treat animals or optimize animal health
06/03/2010US20100137192 Compositions and methods for treating or ameliorating mycobacterial infections
06/03/2010US20100137191 Protective agents for transplanted organs
06/03/2010US20100137190 Liquid composition for external application and preparation for external application for treatment of skin ulcer
06/03/2010US20100137189 Modified globin proteins with altered electron transport pathway
06/03/2010US20100137188 Formulations comprising cyclic compounds
06/03/2010US20100137187 Glutamate-Enhanced Cell-Penetrating Peptides and Methods of Using Same
06/03/2010US20100136628 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells
06/03/2010US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136577 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136550 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease
06/03/2010US20100136528 Fiat nucleic acids and proteins and uses thereof
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136144 Composition containing a quinoa extract for dermatological use
06/03/2010US20100136134 Immune stimulatory infant nutrition
06/03/2010US20100136133 Nutritive compositions and methods of using same
06/03/2010US20100136126 Composition and microsphere for controlled-release of exendin, and method of preparing the same
06/03/2010US20100136121 Medicaments
06/03/2010US20100136120 Compositions and methods for forming and strengthening bone
06/03/2010US20100136115 Pharmaceutical Titanium Dioxide Composite Allowing Disappearance of Drug Efficacy By Light Irradiation
06/03/2010US20100136113 Phytases, nucleic acids encoding them and methods for making and using them
06/03/2010US20100136105 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
06/03/2010US20100136103 Cosmetic anti-ageing skin care compositions
06/03/2010US20100136101 Compositions and methods for sirna inhibition of hif-1 alpha
06/03/2010US20100136100 Removal promoters and inhibitor for apoptosis cells in vivo
06/03/2010US20100136098 Avian influenza vaccine
06/03/2010US20100136097 Systems for modulating inflammation
06/03/2010US20100136096 Systems for modulating inflammation
06/03/2010US20100136095 Systems for modulating inflammation
06/03/2010US20100136094 Systems for modulating inflammation
06/03/2010US20100136092 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
06/03/2010US20100136091 Methods, systems, and compositions for extracellular matrix production
06/03/2010US20100136087 Composition for Promoting Cartilage Formation or Repair Comprising a NELL Gene Product and Method of Treating Cartilage-Related Conditions Using Such Composition
06/03/2010US20100136085 Compositions and methods for arthrodetic procedures
06/03/2010US20100136063 Immunotherapy for Treatment of Amyloid-Related Disorders Using Encapsulated Beta-Amyloid Peptides
06/03/2010US20100136062 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136046 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
06/03/2010US20100136041 Combination gas vaccines and therapeutics
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136038 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
06/03/2010US20100136035 Method for modulating atherosclerosis
06/03/2010US20100136034 Novel multimeric molecules, a process for preparing the same and the use thereof for manufacturing medicinal drugs
06/03/2010US20100136023 Therapeutic agents
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136007 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010US20100136006 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100136001 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
06/03/2010US20100136000 Treatment of follicular lymphomas using inhibitors of the lt pathway
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135995 Methods of modulating angiogenesis
06/03/2010US20100135991 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
06/03/2010US20100135989 Anti-hiv agents
06/03/2010US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof
06/03/2010US20100135984 Anti-inflammatory compositions and methods
06/03/2010US20100135983 Anti-inflammatory compositions and methods
06/03/2010US20100135982 Simethicone solid oral dosage form
06/03/2010US20100135981 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases
06/03/2010US20100135980 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy
06/03/2010US20100135979 Stabilized suspension
06/03/2010US20100135978 Proteases for Pharmaceutical Use
06/03/2010US20100135977 Compositions and methods for treating metabolic diseases
06/03/2010US20100135972 Control of Sucking Lice
06/03/2010US20100135968 Oligodendrocyte Production From Multipotent Neural Stem Cells
06/03/2010US20100135966 Agents for treating flaviviridae infections
06/03/2010US20100135960 Antiviral acylsulfonamide derivatives
06/03/2010US20100135959 Human Interferon Molecules and Their Uses
06/03/2010US20100135958 Method for treating cancer in humans
06/03/2010US20100135957 Chimeric Heteromultimer Adhesins
06/03/2010US20100135956 Steroid modulators of progesterone receptor and/or glucocorticoid receptor
06/03/2010US20100135955 HUMAN M2e PEPTIDE IMMUNOGENS
06/03/2010US20100135954 6-Phenylpyrimidinones as PIM Modulators
06/03/2010US20100135953 Method of treatment of age-related macular degeneration
06/03/2010US20100135952 Methods for the treatment of renal failure
06/03/2010US20100135951 Agents and Methods Related to Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
06/03/2010US20100135948 Anti-Autoimmune Antibodies for Treatment of Pemphigus
06/03/2010US20100135941 Skin-whitening agent
06/03/2010US20100135935 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
06/03/2010US20100135926 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme
06/03/2010US20100135919 Proteolytic enzyme formulations
06/03/2010US20100135904 Compositions and methods for the inhibition of cripto / grp78 complex formation and signaling
06/03/2010US20100135903 Use of a dna damaging agent and a ligand for the treatment of cancer
06/03/2010US20100135901 Combination therapy
06/03/2010US20100135900 Cd37 immunotherapeutic combination therapies and uses thereof
06/03/2010CA2744823A1 Treating neoplasms with neurotoxin
06/03/2010CA2744787A1 Compositions and methods for treatment of celiac disease
06/03/2010CA2744697A1 Use of compositions comprising bile acids, salts, and mimics thereof for treatment of obesity or diabetes
06/03/2010CA2744555A1 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2
06/03/2010CA2743999A1 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds, and uses thereof
1 ... 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 ... 3163